Literature DB >> 16352665

Effects of chronic Akt activation on glucose uptake in the heart.

Takashi Matsui1, Tomohisa Nagoshi, Eun-Gyoung Hong, Ivan Luptak, Kirsten Hartil, Ling Li, Naira Gorovits, Maureen J Charron, Jason K Kim, Rong Tian, Anthony Rosenzweig.   

Abstract

Acute activation of the serine-threonine kinase Akt is cardioprotective and increases glucose uptake, at least in part, through enhanced expression of GLUT4 on the sarcolemma. The effects of chronic Akt activation on glucose uptake in the heart remain unclear. To address this issue, we examined the effects of chronic Akt activation on glucose uptake, glycogen storage, and relevant glucose transporters in the hearts of transgenic mice. We found that chronic cardiac activation of Akt led to a substantial increase in the rate of basal glucose uptake (P < 0.05) but blunted the response to insulin (1.9 vs. 18.1-fold increase compared with baseline) using NMR in ex vivo perfused heart. Basal glucose uptake was also increased in Akt transgenic mice in vivo (P < 0.005). These changes were associated with an increase on glycogen deposition, examined with histochemical staining, biochemical (>6-fold, P < 0.001) and in vivo radioactive (5-fold, P < 0.01) assays. Studies in chimeric hearts of female X-linked transgenic Akt mice suggested that increased glycogen deposition occurred as a cell autonomous effect of transgene expression. Interestingly, although sarcolemmal GLUT1 was not significantly altered, chronic Akt activation actually decreased plasma membrane GLUT4. Moreover, intracellular pools of GLUT1 were modestly reduced, whereas intracellular GLUT4 was substantially reduced. It seems likely that neither GLUT1 nor GLUT4 explains the increase in basal glucose uptake but that these reductions contribute to the loss of insulin responsiveness that we observed. These data demonstrate that chronic Akt activation increases basal glucose uptake and glycogen deposition while inhibiting the response to insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352665     DOI: 10.1152/ajpendo.00564.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  32 in total

Review 1.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

Review 2.  "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation.

Authors:  Mark Sussman
Journal:  Trends Cardiovasc Med       Date:  2007-10       Impact factor: 6.677

Review 3.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

Review 4.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

5.  Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart.

Authors:  Graham R McGinnis; Yawen Tang; Rachel A Brewer; Manoja K Brahma; Haley L Stanley; Gobinath Shanmugam; Namakkal Soorappan Rajasekaran; Glenn C Rowe; Stuart J Frank; Adam R Wende; E Dale Abel; Heinrich Taegtmeyer; Silvio Litovsky; Victor Darley-Usmar; Jianhua Zhang; John C Chatham; Martin E Young
Journal:  J Mol Cell Cardiol       Date:  2017-07-20       Impact factor: 5.000

6.  mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.

Authors:  Xiaoxiao Song; Yoichiro Kusakari; Chun-Yang Xiao; Stuart D Kinsella; Michael A Rosenberg; Marielle Scherrer-Crosbie; Kenta Hara; Anthony Rosenzweig; Takashi Matsui
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

7.  Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis.

Authors:  Svenja Meiler; Yvonne Baumer; Zhi Huang; Fukun W Hoffmann; Gregory J Fredericks; Aaron H Rose; Robert L Norton; Peter R Hoffmann; William A Boisvert
Journal:  J Leukoc Biol       Date:  2013-02-26       Impact factor: 4.962

8.  High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.

Authors:  Anisha A Gupte; Laurie J Minze; Maricela Reyes; Yuelan Ren; Xukui Wang; Gerd Brunner; Mohamad Ghosn; Andrea M Cordero-Reyes; Karen Ding; Domenico Pratico; Joel Morrisett; Zheng-Zheng Shi; Dale J Hamilton; Christopher J Lyon; Willa A Hsueh
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

9.  FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.

Authors:  Yan G Ni; Na Wang; Dian J Cao; Nita Sachan; David J Morris; Robert D Gerard; Makoto Kuro-O; Beverly A Rothermel; Joseph A Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

10.  Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.

Authors:  Eun-Gyoung Hong; Brian W Kim; Dae Young Jung; Jong Hun Kim; Tim Yu; Wagner Seixas Da Silva; Randall H Friedline; Suzy D Bianco; Stephen P Seslar; Hiroko Wakimoto; Charles I Berul; Kerry S Russell; Ki Won Lee; P Reed Larsen; Antonio C Bianco; Jason K Kim
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.